NRAS and carcinoma: Despite the scarcity of genetic studies regarding these lesions, a case report involving a patient with aggressive differentiated carcinoma with multiple DMs (including bone metastases) revealed the presence of the NRAS Q61R hotspot mutation in all the DMs, and concluded that NRAS-mutant thyroid carcinoma exhibited a high risk of developing bone metastases [11].